HOME >> MEDICINE >> NEWS
Drug-eluting stents adopted quickly, with early disparities

DURHAM, N.C. -- In the first comprehensive survey of its kind, Duke Clinical Research Institute researchers have documented that while the adoption of new drug-eluting stents has been rapid, their use has not been universally uniform among patients receiving them.

Furthermore, the researchers said, about one-third of the new stents were placed in patients with clinical characteristics for which such stent use has not yet been approved by the Food and Drug Administration (FDA). However, the researchers said that their finding of a high rate of "off-label" usage should be seen more as an impetus for further clinical trials rather than an immediate safety issue, since cardiologists have been placing traditional stents for more than 10 years and are comfortable with the procedure.

Stents are tiny mesh tubes that are inserted into the site of a blockage in a coronary artery that has been opened during balloon angioplasty. However, a principal complication of the procedure has been the high rate of treated arteries becoming blocked again, a process known as restenosis.

In an attempt to improve stents to keep treated arteries open, stent manufacturers coated them with a chemotherapeutic agent that limits the formation of scar tissue inside the artery. So far, clinical trials have shown that these new stents can reduce the restenosis rate to single digits from the 20 to 30 percent rate of the older stents. The first drug-eluting stent received FDA approval in April, 2003.

"Drug-eluting stents are truly breakthrough products in treating coronary artery disease, and in our analysis of the early trends of the their use, we found disparities in terms of age, race and socio-economic factors," said Duke cardiologist Sunil Rao, M.D., who presented the results of the Duke analysis Nov. 10, 2004, at the American Heart Association's annual scientific sessions in New Orleans.

"We also found that the rate of increased usage for off-label use was
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
10-Nov-2004


Page: 1 2 3

Related medicine news :

1. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis
2. Study says rare allergic reactions to drug-eluting stents may raise risk for heart attack
3. Coronary stents do not improve long-term survival
4. Early reports of thrombosis after insertion of drug-eluting stents
5. Drug-coated stents effective in real world patients
6. Study highlights efficacy of sirolimus stents to prevent restenosis for PTS with CAD
7. Stanford computer model shows bypass surgery more cost-effective than stents
8. Research explores why some internationally adopted children excel while others struggle
9. Mandel School researchers receive $700,000 for study to promote well-being of adopted children
10. Sandia-developed foam likely would stop SARS virus quickly, Sandia/Kansas State team shows
11. New marker for early diagnosis of kidney failure identified

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... ... guide will ensure lab personnel have a basic understanding of the techniques they ... protocols. Enhanced understanding will help them reduce waste and rework to create a ...
(Date:2/9/2016)... ... February 09, 2016 , ... Two renowned photographers, Robert Caplin ... photographic adventure on the island, June 14-19, 2016, hosted by Four Seasons Resort Maui ... , After a successful debut in 2015, the Maui Photo Expedition workshop ...
(Date:2/9/2016)... ... 2016 , ... Sir Grout, the leading hard surface restoration, ... that many of their franchises have received the Super Service Award from Angie's ... received customer recognition through positive reviews and testimonials, as well as evaluations from ...
(Date:2/9/2016)... ... ... Shark Finds and Kevin Harrington, and the Product Managers of AsSeenOnTV.pro are pleased to ... patented product that has solved some of the basic problems golfers have faced since the ... right after a rain shower, might understand the struggle of placing the club down for ...
(Date:2/8/2016)... ... 2016 , ... CURE Media Group , the nation’s leading digital and ... Heroes Awards event , which will annually honor individuals making heroic contributions in the ... MM Heroes Awards nomination process is officially open through February 17 for ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Insulet Corporation (NASDAQ: PODD ) (Insulet or the ... with its OmniPod ® Insulin Management System, ... appointed to Insulet,s Board of Directors. With his appointment, the ... are independent. --> --> ... experience and a deep knowledge of accounting, financial reporting and ...
(Date:2/9/2016)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... fourth quarter and full year 2015 financial results ... genome editing," said Edward Lanphier, Sangamo,s president and ... technology leads the therapeutic genome editing field and ... move our ground-breaking genome editing programs through IND ...
(Date:2/9/2016)... 2016  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... quarter and full year financial results on Tuesday, February ... Company management will host a live audio webcast immediately ... to discuss fourth quarter and full year 2015 financial ... guidance for 2016 financial results. www.jazzpharmaceuticals.com .  ...
Breaking Medicine Technology:
Cached News: